Insider screener

Period: 12 months Type of trade: Sold × Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

20,552 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

20,552 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

20,552 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

20,552 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
20,552 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
20,552 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

20,552 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Jan 2026
Didier Papadopoulos President of Aircraft OEM
Sold on a plan
$157.39K 11,650 at 13.51
8.8%
Planned (10b5-1)
2 Jan 2026
Chris Francis See Remarks
Sold on a plan 2×
$150.26K 9,375 at 16.03
27.3%
Planned (10b5-1)
2 Jan 2026
Kristie Burns Sr. VP Mktg & Clinical Affairs
Sold on a plan
$148.26K 5,139 at 28.85
6.6%
Planned (10b5-1)
2 Jan 2026
Josh D. Paul Chief Accounting Officer
Sold on a plan
$147.85K 800 at 184.81
1.7%
Planned (10b5-1)
2 Jan 2026
Shaunt Voskanian Chief Revenue Officer
Sold on a plan 2×
$146.34K 3,933 at 37.21
0.2%
Planned (10b5-1)
2 Jan 2026
Kate DeHoff See Remarks
Sold at will
$141.64K 10,484 at 13.51
6.0%
Not planned
2 Jan 2026
Edwin C. Reisz Chief Administrative Officer
Sold on a plan
$138.18K 17,613 at 7.85
1.3%
Planned (10b5-1)
2 Jan 2026
Paul L Alpern VP and General Counsel
Sold on a plan 4×
$128.37K 8,309 at 15.45
11.8%
Planned (10b5-1)
2 Jan 2026
Beth Hecht See Remarks
Sold on a plan
$123.78K 16,667 at 7.43
1.3%
Planned (10b5-1)
2 Jan 2026
Jennifer Vecchio Group President and CMO
Sold on a plan 7×
$122.56K 419 at 292.51
0.7%
Planned (10b5-1)
2 Jan 2026
Terrance Lane Wilson SVP & General Counsel
Sold on a plan
$120.22K 2,000 at 60.11
0.7%
Planned (10b5-1)
2 Jan 2026
Steven Ladany SVP Chief Development Officer
Sold on a plan
$115.96K 2,630 at 44.09
4.0%
Planned (10b5-1)
2 Jan 2026
Sold on a plan
$113.75K 10,000 at 11.37
0.5%
Planned (10b5-1)
2 Jan 2026
Andrew Callos EVP, Chief Commercial Officer
Sold on a plan 2×
$112.58K 1,798 at 62.62
3.4%
Planned (10b5-1)
2 Jan 2026
Craig C. Hopkinson EVP R&D, Chief Medical Officer
Sold on a plan
$112.00K 4,000 at 28.00
6.1%
Planned (10b5-1)
2 Jan 2026
Daniel William Moore PFO and PAO
Sold at will
$111.94K 5,477 at 20.44
4.8%
Not planned
2 Jan 2026
Mark Haymond Robinson General Counsel and Secretary
Sold at will
$111.90K 5,475 at 20.44
4.5%
Not planned
2 Jan 2026
Donna M. Long SVP, CIO
Sold on a plan 3×
$100.49K 812 at 123.75
4.3%
Planned (10b5-1)
2 Jan 2026
Patrick A. Cunningham Chief Compliance Officer
Sold on a plan
$97.63K 12,445 at 7.85
4.1%
Planned (10b5-1)
2 Jan 2026
Paul D Rubin Chief Medical Officer
Sold on a plan
$95.49K 7,433 at 12.85
100%
Sold half or more
2 Jan 2026
Deborah Stewart SVP, Chief Accounting Officer
Sold on a plan
$93.84K 11,962 at 7.85
4.5%
Planned (10b5-1)
2 Jan 2026
Tyler Herb Chief Accounting Officer
Sold on a plan 2×
$89.60K 2,408 at 37.21
1.2%
Planned (10b5-1)
2 Jan 2026
Christopher M Crain General Counsel
Sold on a plan
$87.09K 500 at 174.17
100%
Sold half or more
2 Jan 2026
Steven M Chaouki President, US Markets
Sold on a plan
$85.71K 1,000 at 85.71
1.6%
Planned (10b5-1)
2 Jan 2026
Laurent R Moll Chief Operating Officer
Sold at will 3×
$83.00K 5,373 at 15.45
2.1%
Not planned
2 Jan 2026
Sold on a plan
$79.49K 729 at 109.04
11.1%
Planned (10b5-1)
2 Jan 2026
Paulina Klimenko Chief Growth Officer
Sold at will
$77.69K 9,020 at 8.61
12.3%
Not planned
2 Jan 2026
Ajmere Dale Chief Accounting Officer
Sold on a plan 2×
$76.35K 1,173 at 65.09
1.2%
Planned (10b5-1)
2 Jan 2026
Alec Amar President
Sold on a plan
$74.80K 27,500 at 2.72
2.1%
Planned (10b5-1)
2 Jan 2026
Eric Allison Chief Product Officer
Sold at will
$73.59K 5,447 at 13.51
0.8%
Not planned
2 Jan 2026
Anthony J Recupero President, Commercial Ops
Sold at will 2×
$72.14K 3,677 at 19.62
1.4%
Not planned
2 Jan 2026
Michael A. Pisetsky SVP, Ops & Adm/Chief Legal Ofr
Sold at will 3×
$67.90K 3,460 at 19.62
1.5%
Not planned
2 Jan 2026
Brian Grassadonia Ecosystem Lead
Sold on a plan
$66.41K 1,038 at 63.98
0.2%
Planned (10b5-1)
2 Jan 2026
William M Sheriff See Remarks
Sold on a plan
$65.28K 24,000 at 2.72
1.1%
Planned (10b5-1)
2 Jan 2026
Jonathan D. Lee Chief Accounting Officer
Sold at will
$63.28K 2,679 at 23.62
2.1%
Not planned
2 Jan 2026
Malik Ducard Chief Content Officer
Sold on a plan
$60.03K 2,293 at 26.18
0.3%
Planned (10b5-1)
2 Jan 2026
Jared F. Sine Chief Strategy & Legal Officer
Sold on a plan
$58.71K 475 at 123.61
0.8%
Planned (10b5-1)
2 Jan 2026
Gregory Bowles Chief Policy Officer
Sold at will
$56.66K 4,194 at 13.51
2.5%
Not planned
2 Jan 2026
Khurram Jamil Chief Medical Officer
Sold on a plan
$54.79K 13,055 at 4.20
21.8%
Planned (10b5-1)
2 Jan 2026
Owen Britton Jennings Business Lead
Sold at will
$52.59K 822 at 63.98
0.3%
Not planned
2 Jan 2026
Francis Lo Chief People Officer
Sold on a plan
$50.25K 3,125 at 16.08
1.0%
Planned (10b5-1)
2 Jan 2026
William M Sheriff See Remarks · indirect
Sold on a plan 2×
$49.56K 18,500 at 2.68
59.0%
Sold half or more
2 Jan 2026
Amar K. Goel Chairman, Chief Innovation Off
Sold on a plan
$45.47K 5,279 at 8.61
21.2%
Planned (10b5-1)
2 Jan 2026
Philip S. Kurtz CLO & Corp. Secretary
Sold at will 2×
$43.26K 11,121 at 3.89
9.2%
Not planned
2 Jan 2026
Todd C. Skinner President, International
Sold on a plan
$42.86K 500 at 85.71
1.5%
Planned (10b5-1)
2 Jan 2026
Andrew Woods General Counsel & Secretary
Sold at will
$42.04K 4,881 at 8.61
7.5%
Not planned
2 Jan 2026
Kuanling Amy Yeh Chief Technology Officer
Sold on a plan
$38.85K 3,000 at 12.95
0.8%
Planned (10b5-1)
2 Jan 2026
Zachariah McIver Chief Medical Officer
Sold at will
$37.26K 2,714 at 13.73
10.4%
Not planned
2 Jan 2026
Craig Saldanha Chief Product Officer
Sold on a plan
$36.52K 1,200 at 30.43
0.6%
Planned (10b5-1)
2 Jan 2026
Thomas DiRaimondo Chief Scientific Officer
Sold at will
$34.39K 2,505 at 13.73
2.0%
Not planned
Showing 17,501–17,550 of 20,552. ← Newer Page 351 of 412 Older →